explore -WSS

explore

author：fashion 2025-08-24 23:09:53 - browse：6

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Explaining an after

WSS

Many immigrants are left out of maternal health programs

5 wounded, 2 critically, in Michigan shopping center shooting

How to convince healthy people to buy insurance

Gene therapy’s promise and the high cost of hope

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Lung cancer screening guidelines updated for cigarette smokers

entertainment

explore

hotspot

Virginia high school admissions case could be legal follow

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Affirmative action in medical school literally saved lives

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

In age of alternative facts, a scholarly course on calling out crap

Medicare proceeds with plan to claw back hospital funds

BioMarin wins approval for gene therapy to treat hemophilia A

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Malaria cases in Florida and Texas: Here’s what you need to know

Judge orders hearing on Trump's motion to disqualify Fulton County DA

entertainment

All of Us, NIH's precision medicine initiative, gets a big boost

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

What is microchimerism and how does it affect maternal health?

House GOP plan to stem drug shortages differs from Democrats’

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

entertainment

entertainment

hotspot

focus